Skip to main content
G

Grape King Bio Ltd. — Investor Relations & Filings

Ticker · 1707 TW Manufacturing
Filings indexed 2,084 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About Grape King Bio Ltd.

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings
2026-05-05 Chinese
115年04月董事會成員及持股
Regulatory Filings
2026-05-05 Chinese
公告本公司115年第一季財務報告 董事會預計召開日期為115年5月11日
Regulatory Filings
2026-04-30 Chinese
115年年報及股東會資料 — 2025_1707_20260526FE4.pdf
Regulatory Filings
2026-04-29 Chinese
115年年報及股東會資料 — 2025_1707_20260526F04.pdf
Regulatory Filings
2026-04-29 Chinese
114年年報及股東會資料 — 2026_1707_20260526F17.pdf
Regulatory Filings Classification · 1% confidence The document is a standalone table listing the top ten shareholders and their relationships, presented in a statutory format (ROC calendar dates, share counts, relationship disclosures). It is not a full annual report (10-K) or other comprehensive filing. It does not announce a report’s publication, nor does it fit specific categories like share issue, insider dealing, proxy materials, or financial statements. It is therefore best classified as a general regulatory filing fallback.
2026-04-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.